All articles by  

  1. BeiGene obtains certain rights for Leap Therapeutics’ cancer drug

    Chinese biopharmaceutical firm BeiGene has agreed to exclusive rights to develop and commercialise Leap Therapeutics’ cancer drug DKN-01 in the…
    Read More…

    6 Jan
  2. Season’s Greetings

    Pharmaceutical-technology.com will be taking a short break over the holiday season. Our full daily news service will return on 6…
    Read More…

    23 Dec
  3. AstraZeneca sells Arimidex and Casodex rights for $181m

    AstraZeneca has divested the commercial rights to Arimidex (anastrozole) and Casodex (bicalutamide) to French pharmaceutical company Juvisé Pharmaceuticals for an…
    Read More…

    20 Dec
  4. Merck secures FDA authorisation for Ebola vaccine Ervebo

    Merck (MSD) has received the US Food and Drug Administration (FDA) approval for its Ervebo vaccine to prevent Ebola virus…
    Read More…

    20 Dec
  5. Roche gets European approval for Kadcyla to treat breast cancer

    Roche has received approval from the European Commission for Kadcyla (trastuzumab emtansine) as an adjuvant therapy to treat adults with…
    Read More…

    20 Dec
  6. GBT and Syros team up on new therapies for blood disorders

    Global Blood Therapeutics (GBT) has signed an agreement with Syros Pharmaceuticals for the discovery, development and commercialisation of therapies to…
    Read More…

    19 Dec
  7. US proposes rules for drug importation from Canada

    US President Donald Trump, the Department of Health and Human Services (HHS) and the US Food and Drug Administration (FDA)…
    Read More…

    19 Dec
  8. FDA approves Astellas-Seattle Genetics’ bladder cancer drug

    The US Food and Drug Administration (FDA) has granted accelerated approval to Astellas Pharma and Seattle Genetics’ Padcev drug to…
    Read More…

    19 Dec
  9. Vyera licences HIV treatment from CytoDyn

    Vyera Pharmaceuticals has entered agreements with CytoDyn to commercialise human immunodeficiency viruses (HIV) treatment leronlimab (PRO 140) in the US….
    Read More…

    18 Dec
  10. Triplet Therapeutics launches to focus on Huntington’s disease drugs

    Biotechnology company Triplet Therapeutics has launched to develop treatments for more than 40 triplet repeat disorders, including Huntington’s disease. The…
    Read More…

    18 Dec
Close
Close
Close

Go Top